M-2: PHI Pharmacist: TB Treatment
Fullscreen
-
Ph-Ch6: General concepts in TB Treatment
FullscreenGoals of treatment
Strategies for TB Treatment
Pharmacological Basis of treatment
Treatment Phases
Fixed Dose Combinations [FDC]s
Advantages of FDCs
FDCs used in NTEP
TB Drug Regimen
TB patient follow up
Long Term Post-treatment follow up of TB patients
TB Treatment Outcome
Adverse Drug Reactions
Types of ADR of TB Treatment
Management of Adverse Drug Reactions(ADRs) of TB Treatment
TB Treatment Card
NTEP TB ID Card
Transfer of TB Patient
Management of EPTB
Management of Patients with Treatment Interruptions
H5ContentPrevention of Drug Resistance
Treatment Regimen for Non-Mycobacterium Tuberculosis [NTM]
-
Ph-Ch7: DS-TB Treatment and care
-
PHI Pharmacist : DR-TB TREATMENT AND CARE
FullscreenDrug-Resistant Tuberculosis(DR-TB)
Goals of DR-TB Treatment
Screening for DR-TB
Types of Drug Resistance Tuberculosis -DRTB
H5ContentDR-TB Treatment Regimens
Pre-treatment Evaluation [PTE] of DR-TB Patients
Second Line anti TB drugs
Newer Anti-TB Drugs
Weight Band-wise Dosages of DR-TB Drugs for Adults
Treatment of DR-TB in Children
H5ContentAdverse Drug Reactions(ADRs) to Second Line Treatment
Reporting of Adverse Events and Serious Adverse Events
-
Ph-Ch9: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
FullscreenShorter oral Bedaquiline-containing MDR/RR-TB regimen
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Dosage of Drugs for Adults
Possible Adverse Events Due to Drugs in Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
-
Ph-Ch10: Longer Oral M/XDR-TB Regimen
-
Ph-Ch11: Isoniazid (H) Mono/Poly DR-TB Regimen
-
Ph-Ch12: TB Infection treatment and care
Fullscreen -
Ph-Ch13: TB-Comorbidities and special situations
-
PHI Pharmacist : GENERAL CONCEPTS IN ADHERENCE MANAGEMENT